State Street’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.95K Hold
572
﹤0.01% 4260
2025
Q4
$15.9K Hold
572
﹤0.01% 4255
2025
Q3
$43.7K Buy
+572
New +$284K ﹤0.01% 4172
2023
Q1
Sell
-200
Closed -$381K 4804
2022
Q4
$381K Buy
200
+154
+335% +$61K ﹤0.01% 3861
2022
Q3
$25K Sell
46
-59
-56% -$46.3K ﹤0.01% 4792
2022
Q2
$79K Sell
105
-385
-79% -$604K ﹤0.01% 4609
2022
Q1
$1.69M Buy
490
+43
+10% +$113K ﹤0.01% 3635
2021
Q4
$1.35M Buy
447
+2
+0.4% +$9.28K ﹤0.01% 3744
2021
Q3
$2.91M Buy
445
+116
+35% +$1M ﹤0.01% 3507
2021
Q2
$4.36M Buy
329
+49
+18% +$770K ﹤0.01% 3314
2021
Q1
$4.72M Sell
280
-7
-2% -$137K ﹤0.01% 3075
2020
Q4
$4.87M Sell
287
-10
-3% -$188K ﹤0.01% 2971
2020
Q3
$5.56M Hold
297
﹤0.01% 2727
2020
Q2
$7.8M Buy
297
+125
+73% +$3.54M ﹤0.01% 2553
2020
Q1
$3.77M Buy
172
+27
+19% +$431K ﹤0.01% 2767
2019
Q4
$1.34M Buy
145
+16
+12% +$155K ﹤0.01% 3359
2019
Q3
$1.23M Buy
129
+23
+22% +$280K ﹤0.01% 3360
2019
Q2
$1.7M Buy
106
+17
+19% +$282K ﹤0.01% 3298
2019
Q1
$1.84M Buy
89
+8
+10% +$142K ﹤0.01% 3183
2018
Q4
$993K Buy
81
+3
+4% +$52K ﹤0.01% 3330
2018
Q3
$1.93M Buy
78
+1
+1% +$30.5K ﹤0.01% 3257
2018
Q2
$2.65M Sell
77
-4
-5% -$153K ﹤0.01% 3142
2018
Q1
$3.21M Buy
81
+48
+145% +$1.82M ﹤0.01% 2985
2017
Q4
$1.55M Buy
33
+10
+43% +$468K ﹤0.01% 3259
2017
Q3
$1.29M Buy
+23
New +$1.26M ﹤0.01% 3327

Other funds holding KALA

State Street's KALA Position: Q1 2026 in Review

State Street held its KALA BIO (KALA) position steady in Q1 2026 at 572 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4260.

State Street first reported a position in KALA in Q3 2017 and has held it in 25 quarters since. The position peaked at $7.8M in Q2 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • State Street held 572 shares of KALA BIO worth $4.95K as of Q1 2026.
  • State Street left its KALA BIO share count unchanged in Q1 2026.
  • KALA BIO made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4260 holding.
  • State Street first reported a position in KALA BIO in Q3 2017 and has held it in 25 quarters since.
  • State Street's KALA BIO position peaked at $7.8M in Q2 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.